D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

Launched by GENERAL COMMITTEE OF TEACHING HOSPITALS AND INSTITUTES, EGYPT · Sep 19, 2023

Keywords

ClinConnect Summary

This clinical trial is studying two different surgical techniques, called D2 and D3 lymphadenectomy, to see which one is better for patients undergoing laparoscopic right hemicolectomy for right-side colon cancer. The goal is to compare how these techniques affect things like blood loss during surgery, the need for blood transfusions, recovery in the intensive care unit, leaks from the surgical connection, the number of lymph nodes removed, and overall survival rates after five years.

To participate in this trial, patients need to have right-side colon cancer, which can be found in areas like the cecum or ascending colon. They must have been diagnosed using a CT scan, colonoscopy, and biopsy. However, patients who have emergency surgery needs, metastatic tumors (cancer that has spread), or other serious health issues may not be eligible. If you join this trial, you will receive care and follow-up for six months to monitor your recovery and health outcomes. This study is currently not recruiting participants, so it's important to stay updated if you're interested.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with right-side colon cancer (caecum, ascending, or hepatic flexure)
• • Diagnosed by CT entero-colonography
• • Diagnosed by colonoscopy
• • Diagnosed by biopsy.
• Exclusion Criteria:
• • Emergency surgery (obstruction, perforation with generalized peritonitis),
• • Metastatic tumor diagnosed
• • ASA score of IV or higher
• • Need for more than one surgical procedure
• • Conversion to open surgery